Author Contributions: Drs Hudson and Ness had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Drs Hudson and Ness contributed equally to the manuscript.
Study concept and design: Hudson, Gurney, Krull, Armstrong, Srivastava, Robison.
Acquisition of data: Hudson, Ness, Gurney, Chemaitilly, Krull, Armstrong, Nottage, Robison.
Analysis and interpretation of data: Hudson, Ness, Gurney, Mulrooney, Chemaitilly, Krull, Green, Armstrong, Nottage, Jones, Sklar, Srivastava, Robison.
Drafting of the manuscript: Hudson, Ness, Mulrooney, Chemaitilly, Green, Armstrong, Nottage, Srivastava, Robison.
Critical revision of the manuscript for important intellectual content: Hudson, Ness, Gurney, Mulrooney, Chemaitilly, Krull, Armstrong, Nottage, Jones, Sklar, Srivastava, Robison.
Statistical analysis: Ness, Nottage, Jones, Srivastava, Robison.
Obtained funding: Robison.
Administrative, technical, or material support: Hudson, Ness, Gurney, Krull, Robison.
Study supervision: Hudson, Ness, Mulrooney, Armstrong, Sklar, Srivastava, Robison.
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Sklar reported serving as a consultant for Novo Nordisk. Dr Srivastava reported serving as a consultant for SRA Consultancy. Dr Robison reported serving as a board member for Eli Lilly. No other authors reported disclosures.
Funding/Support: This study was supported by Cancer Center Support (CORE) grant CA 21765 from the National Cancer Institute (NCI) and by the American Lebanese Syrian Associated Charities (ALSAC).
Role of the Sponsor: The NCI and ALSAC had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; the preparation, review, or approval of the manuscript; or the decision to submit the manuscript for publication.
Previous Presentation: An abstract from the preliminary analysis was presented at the 43rd Congress of the International Society of Paediatric Oncology; October 25-30, 2011; Auckland, New Zealand.
Additional Contributions: We are grateful for the considerable efforts of the research, clinical, and administrative staff who support the St Jude Lifetime Cohort Study and the survivors and their families from whom it is our privilege to learn.
This article was corrected for errors on June 11, 2013.